Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Licenses Geospiza's Software to Provide NGS Data Analysis and Management

Premium

PerkinElmer has licensed Geospiza's GeneSifter Lab Edition and GeneSifter Analysis Edition software to provide laboratory management and data analysis for a next-generation sequencing service that it launched this week.

Dick Begley, PE's president of emerging technologies, said in a statement that the GeneSifter tool suite "fit our need for a robust and scalable lab workflow and analysis system," noting the products provide a "comprehensive software platform" that’s needed to "manage the complexities of next-gen sequencing operations."

PE launched its sequencing and analysis service this week to provide human and mouse exome resequencing services for customers looking to outsource their sequencing needs. Operating out of a sequencing lab based in Branford, Conn., its list of services includes project planning and consultation as well as sample processing and library preparation, among others.

Furthermore, the company launched an Internet-enabled "private cloud" to provide its clients with "secure" web-based access to their genomic data as well as storage space.

PerkinElmer did not provide details of its computational infrastructure.

The firm is using Illumina's HiSeq 2000 to handle its sequencing needs as well as Agilent SureSelect, Illumina's TruSeq, and Nimblegen EZ Exome for exome capture.

The company also plans to use its Janus Automated Workstations and EnSpire Plate Readers for sample processing and automation.

PE expects the turnaround time for the service to be between four and six weeks. Of that, sample prep and sequencing comprise approximately 15 days, with the remainder comprising data analysis.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.